Slope Clinical
Year2021
RoundSeries A
Amount$20M
Overall
Summary
10 slides
10 slides
1 slide
We're Slope and we strive to make clinical trials as uneventful as possible, meaning we aim for efficiency and predictability.
1 slide
The market is facing significant operational complexity, causing delays in clinical trials. Slope offers a software platform to streamline and automate these processes, and we're seeking $20M Series A funding to scale our efforts.
1 slide
Slope's founders come from diverse backgrounds in software development, supply chain management, and healthcare, bringing together their unique expertise to tackle inefficiencies in clinical trials.
3 slides
Clinical trial sites are often unprepared for patient visits, and modern study designs are becoming increasingly complex, requiring more samples. Project managers rely on archaic tools like spreadsheets to manage these complexities manually.
1 slide
Slope's solution is a software platform that automates and orchestrates highly complex studies by creating structured workflows and connecting all the stakeholders in real-time.
1 slide
With over 4,500 global users and 660 research sites, along with the management of 50,000+ samples and kits, Slope is well-positioned for exponential growth.
1 slide
Slope’s business model includes a mix of one-time study startup fees, monthly fees based on connected sites and vendors, and activity-based fulfillment and shipping fees. This ensures the platform scales with the studies.
1 slide
Our platform's proven approach saves an average of over 13 hours per patient visit, significantly automating various workflows for research sites, labs, and kitting services.
